12:00 AM
 | 
Apr 17, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Universal PLAS+SDL: Began Phase III trial

The first generation version of PLAS+SD, which is marketed, has viruses removed through a solvent detergent process, while Universal PLAS+SD has blood type specific antibodies removed...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >